tiprankstipranks
Trending News
More News >
Idexx Laboratories (CH:IX1)
:IX1
Switzerland Market
Advertisement

Idexx Laboratories (IX1) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

IX1 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Idexx
Laboratories
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IX1 Stock 12 Month Forecast

There Are No Analyst Ratings for CH:IX1 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IX1 Financial Forecast

IX1 Earnings Forecast

Next quarter’s earnings estimate for IX1 is $2.33 with a range of $2.19 to $2.43. The previous quarter’s EPS was $2.74. IX1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year IX1 has Preformed in-line its overall industry.
Next quarter’s earnings estimate for IX1 is $2.33 with a range of $2.19 to $2.43. The previous quarter’s EPS was $2.74. IX1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year IX1 has Preformed in-line its overall industry.

IX1 Sales Forecast

Next quarter’s sales forecast for IX1 is $851.42M with a range of $835.46M to $861.16M. The previous quarter’s sales results were $889.58M. IX1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year IX1 has Preformed in-line its overall industry.
Next quarter’s sales forecast for IX1 is $851.42M with a range of $835.46M to $861.16M. The previous quarter’s sales results were $889.58M. IX1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year IX1 has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:IX1
Stifel Nicolaus
Stifel Nicolaus
CHF508.99CHF556.7
Buy
Upgraded
10/30/25
Stifel Nicolaus upgrades Idexx Laboratories (IDXX) to a Buy
TR | OpenAI - 4o Analyst forecast on CH:IX1
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF567.04
Buy
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
William Blair Analyst forecast on CH:IX1
William Blair
William Blair
Buy
Reiterated
10/22/25
Idexx Laboratories' Innovative Diagnostics Drive Buy Rating Amid Strong Growth Prospects
Leerink Partners Analyst forecast on CH:IX1
Leerink Partners
Leerink Partners
CHF592.49
Buy
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (NASDAQ: IDXX), Cencora (NYSE: COR) and Amgen (NASDAQ: AMGN)
UBS
CHF572.61
Hold
Initiated
10/01/25
Idexx Laboratories: Balancing Growth Opportunities and Revenue Challenges in a High-Growth Sector
Jefferies Analyst forecast on CH:IX1
Jefferies
Jefferies
CHF624.3
Buy
Reiterated
08/18/25
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Medtronic (NYSE: MDT) and Idexx Laboratories (NASDAQ: IDXX)
Morgan Stanley Analyst forecast on CH:IX1
Morgan Stanley
Morgan Stanley
CHF574.2CHF608.4
Buy
Reiterated
08/15/25
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (NASDAQ: IDXX) and Aardvark Therapeutics, Inc. (NASDAQ: AARD)
BTIG
CHF624.3
Buy
Reiterated
08/15/25
Idexx Laboratories (IDXX) Gets a Buy from BTIG
Piper Sandler Analyst forecast on CH:IX1
Piper Sandler
Piper Sandler
CHF405.6CHF556.7
Hold
Reiterated
08/11/25
Piper Sandler Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)
Bank of America Securities Analyst forecast on CH:IX1
Bank of America Securities
Bank of America Securities
CHF437.41CHF556.7
Hold
Reiterated
08/04/25
Idexx Laboratories Hold Rating: Balancing Market Softness with Potential Product Growth
J.P. Morgan Analyst forecast on CH:IX1
J.P. Morgan
J.P. Morgan
CHF437.41CHF536.82
Buy
Reiterated
08/04/25
Idexx Laboratories price target raised to $675 from $550 at JPMorganIdexx Laboratories price target raised to $675 from $550 at JPMorgan
Barclays
CHF413.55
Buy
Reiterated
02/04/25
Barclays Sticks to Its Buy Rating for Idexx Laboratories (IDXX)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on CH:IX1
Stifel Nicolaus
Stifel Nicolaus
CHF508.99CHF556.7
Buy
Upgraded
10/30/25
Stifel Nicolaus upgrades Idexx Laboratories (IDXX) to a Buy
TR | OpenAI - 4o Analyst forecast on CH:IX1
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF567.04
Buy
Reiterated
10/30/25
AI Generated ArticleAI Generated Article
William Blair Analyst forecast on CH:IX1
William Blair
William Blair
Buy
Reiterated
10/22/25
Idexx Laboratories' Innovative Diagnostics Drive Buy Rating Amid Strong Growth Prospects
Leerink Partners Analyst forecast on CH:IX1
Leerink Partners
Leerink Partners
CHF592.49
Buy
Reiterated
10/03/25
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (NASDAQ: IDXX), Cencora (NYSE: COR) and Amgen (NASDAQ: AMGN)
UBS
CHF572.61
Hold
Initiated
10/01/25
Idexx Laboratories: Balancing Growth Opportunities and Revenue Challenges in a High-Growth Sector
Jefferies Analyst forecast on CH:IX1
Jefferies
Jefferies
CHF624.3
Buy
Reiterated
08/18/25
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Medtronic (NYSE: MDT) and Idexx Laboratories (NASDAQ: IDXX)
Morgan Stanley Analyst forecast on CH:IX1
Morgan Stanley
Morgan Stanley
CHF574.2CHF608.4
Buy
Reiterated
08/15/25
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (NASDAQ: IDXX) and Aardvark Therapeutics, Inc. (NASDAQ: AARD)
BTIG
CHF624.3
Buy
Reiterated
08/15/25
Idexx Laboratories (IDXX) Gets a Buy from BTIG
Piper Sandler Analyst forecast on CH:IX1
Piper Sandler
Piper Sandler
CHF405.6CHF556.7
Hold
Reiterated
08/11/25
Piper Sandler Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)
Bank of America Securities Analyst forecast on CH:IX1
Bank of America Securities
Bank of America Securities
CHF437.41CHF556.7
Hold
Reiterated
08/04/25
Idexx Laboratories Hold Rating: Balancing Market Softness with Potential Product Growth
J.P. Morgan Analyst forecast on CH:IX1
J.P. Morgan
J.P. Morgan
CHF437.41CHF536.82
Buy
Reiterated
08/04/25
Idexx Laboratories price target raised to $675 from $550 at JPMorganIdexx Laboratories price target raised to $675 from $550 at JPMorgan
Barclays
CHF413.55
Buy
Reiterated
02/04/25
Barclays Sticks to Its Buy Rating for Idexx Laboratories (IDXX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Idexx Laboratories

1 Month
xxx
Success Rate
7/11 ratings generated profit
64%
Average Return
+5.06%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +5.06% per trade.
3 Months
xxx
Success Rate
9/11 ratings generated profit
82%
Average Return
+12.78%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +12.78% per trade.
1 Year
Jonathan BlockStifel Nicolaus
Success Rate
25/29 ratings generated profit
Average Return
+32.99%
upgraded a buy rating 5 days ago
Copying Jonathan Block's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of +32.99% per trade.
2 Years
xxx
Success Rate
9/11 ratings generated profit
82%
Average Return
+35.92%
reiterated a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +35.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IX1 Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
8
9
14
22
21
Hold
8
6
5
5
6
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
16
15
19
28
28
In the current month, IX1 has received 21 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. IX1 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

IX1 Stock Forecast FAQ

What is CH:IX1’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:IX1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:IX1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Idexx Laboratories a Buy, Sell or Hold?
      Currently, no data Available
      What is Idexx Laboratories’s share price target?
      Currently, no data Available
      What do analysts say about Idexx Laboratories?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Idexx Laboratories?
      To buy shares of CH:IX1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis